SC closes suo motu procedures to probe bigger conspiracy to frame ex

NEW DELHI: The Supreme Court on Thursday closed the proceedings initiated to penetrate a bigger conspiracy to frame ex-CJI Ranjan Gogoi in a supposed unwanted sexual advances case and “fixing” of benches in the leading court.A bench headed by Justice Sanjay Kishan Kaul said that almost 2 years have passed and the possibility of recovering electronic records is extremely less in the probe.The top court, while closing the suo motu case in the event, stated the internal proceedings has currently completed the probe into the unwanted sexual advances allegations against then CJI Gogoi and the three-member panel headed by Justice S A Bobde, now the CJI, has currently provided the report exonerating him.The bench likewise comprising justices AS Bopanna and V Ramasubramanian stated that the Justice (retd) AK Patnaik panel was not able to get electronic records like WhatsApp messages to penetrate into the conspiracy and hence no purpose would be served by continuing with the suo motu case.The top court referred to the letter of the Director of Intelligence Bureau that some conspiracy may have occurred due to some tough decisions taken by former Chief Justice Gogoi like verdict on preparation of the National Register for Citizens (NRC) in Assam.There are strong reasons to think that some kind of conspiracy might have been undertaken versus the then CJI Gogoi, the bench said, while pricing quote the report of Justice Patnaik.It stated, in view of the mandate of the order dated April 25, 2019 Justice Patnaik’s report believes that it can not truly ask whether the decisions of the then CJI on the judicial side had actually triggered the conspiracy versus Gogoi.On April 25, 2019, the top court had selected Justice Patnaik to hold an inquiry into the spectacular accusations of a lawyer about “larger conspiracy” to frame Chief Justice of India Ranjan Gogoi and fixing of benches in the leading court.

Please follow and like us:

Check Also

United States FDA approves Johnson & Johnson’s single dosage COVID 19 vaccine

“Initial results from a large trial in the United States, Latin America and South Africa …

RSS
LinkedIn
Share